Current and future indications for deep brain stimulation in pediatric populations.
Deep brain stimulation (DBS) has proven to be an effective and safe treatment option in patients with various advanced and treatment-refractory conditions. Thus far, most of the experience with DBS has been in the movement disorder literature, and more specifically in the adult population, where its use in conditions such as Parkinson disease has revolutionized management strategies. The pediatric population, however, can also be afflicted by functionally incapacitating neurological conditions that remain refractory despite the clinicians' best efforts. In such cases, DBS offers an additional treatment alternative. In this paper, the authors review their institution's experience with DBS in the pediatric population, and provide an overview of the literature on DBS in children. The authors conclude that DBS in children can and should be considered a valid and effective treatment option, albeit in highly specific and carefully selected cases.
Lipsman
Nir
N
Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Ontario, Canada.
Ellis
Michael
M
Lozano
Andres M
AM
D000328:Adult; D000367:Age Factors; D002648:Child; D046690:Deep Brain Stimulation / Q000941:ethics / Q000379:methods* / Q000639:trends; D004421:Dystonia / Q000628:therapy; D004827:Epilepsy / Q000628:therapy; D005544:Forecasting; D006801:Humans; D009069:Movement Disorders / Q000628:therapy; D009128:Muscle Spasticity / Q000628:therapy; D009771:Obsessive-Compulsive Disorder / Q000628:therapy; D016896:Treatment Outcome